Financial Snapshot

Revenue
$711.4M
TTM
Gross Margin
25.06%
TTM
Net Earnings
-$133.7M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
297.48%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$1.403B
Q3 2024
Cash
Q3 2024
P/E
-7.961
Nov 29, 2024 EST
Free Cash Flow
-$200.0M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Revenue $863.5M $1.004B $1.775B $1.435B $901.9M $990.3M $966.0M $1.117B $447.5M $91.13M $96.53M $47.04M $27.98M $28.50M $4.400M $9.400M $800.0K $0.00 $0.00 $0.00 $0.00 $600.0K $1.300M $900.0K $1.400M $1.200M $0.00 $0.00 $0.00
YoY Change -14.01% -43.42% 23.64% 59.15% -8.92% 2.51% -13.56% 149.71% 391.1% -5.6% 105.19% 68.14% -1.83% 547.73% -53.19% 1075.0% -100.0% -53.85% 44.44% -35.71% 16.67%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Revenue $863.5M $1.004B $1.775B $1.435B $901.9M $990.3M $966.0M $1.117B $447.5M $91.13M $96.53M $47.04M $27.98M $28.50M $4.400M $9.400M $800.0K $0.00 $0.00 $0.00 $0.00 $600.0K $1.300M $900.0K $1.400M $1.200M $0.00 $0.00 $0.00
Cost Of Revenue $545.3M $716.0M $1.193B $894.4M $572.5M $604.6M $559.0M $564.1M $193.3M $9.372M $10.42M $27.88M $17.24M $13.50M $2.900M $8.600M $800.0K
Gross Profit $318.2M $288.2M $581.5M $541.0M $329.5M $385.6M $407.1M $553.4M $254.2M $81.75M $86.11M $19.17M $10.74M $15.00M $1.500M $900.0K $0.00
Gross Profit Margin 36.85% 28.7% 32.77% 37.69% 36.53% 38.94% 42.14% 49.52% 56.8% 89.72% 89.21% 40.74% 38.37% 52.63% 34.09% 9.57% 0.0%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Selling, General & Admin $300.6M $372.7M $468.9M $355.6M $343.3M $358.3M $414.6M $407.3M $172.1M $57.94M $55.32M $27.80M $19.17M $18.10M $10.40M $14.80M $12.50M $1.100M $1.400M $2.100M $2.900M $4.800M $6.400M $5.800M $3.200M $2.500M $1.900M $1.500M $1.100M
YoY Change -19.35% -20.51% 31.86% 3.57% -4.2% -13.57% 1.79% 136.63% 197.1% 4.74% 99.03% 45.0% 5.91% 74.04% -29.73% 18.4% 1036.36% -21.43% -33.33% -27.59% -39.58% -25.0% 10.34% 81.25% 28.0% 31.58% 26.67% 36.36% 0.0%
% of Gross Profit 94.46% 129.3% 80.63% 65.73% 104.19% 92.93% 101.86% 73.61% 67.71% 70.87% 64.24% 145.02% 178.55% 120.67% 693.33% 1644.44%
Research & Development $89.59M $73.89M $76.85M $75.32M $117.9M $125.6M $126.4M $113.9M $101.8M $83.57M $53.90M $19.52M $11.35M $5.900M $10.80M $21.60M $10.90M $0.00 $200.0K $3.900M $4.800M $3.700M $2.300M $1.700M $1.500M $1.600M $1.200M
YoY Change 21.26% -3.86% 2.04% -36.1% -6.14% -0.67% 11.03% 11.85% 21.82% 55.04% 176.14% 71.95% 92.41% -45.37% -50.0% 98.17% -100.0% -94.87% -18.75% 29.73% 60.87% 35.29% 13.33% -6.25% 33.33% 20.0%
% of Gross Profit 28.16% 25.64% 13.22% 13.92% 35.77% 32.57% 31.06% 20.58% 40.05% 102.22% 62.6% 101.85% 105.74% 39.33% 720.0% 2400.0%
Depreciation & Amortization $105.3M $108.7M $78.72M $85.36M $93.81M $97.34M $102.1M $96.58M $42.25M $14.93M $15.22M $10.16M $3.830M $2.200M $600.0K $1.800M $200.0K $0.00 $0.00 $0.00 $100.0K $500.0K $300.0K $300.0K $200.0K $100.0K $100.0K $100.0K $100.0K
YoY Change -3.09% 38.03% -7.79% -9.0% -3.63% -4.65% 5.71% 128.59% 183.03% -1.9% 49.76% 165.27% 74.09% 266.67% -66.67% 800.0% -100.0% -80.0% 66.67% 0.0% 50.0% 100.0% 0.0% 0.0% 0.0% 0.0%
% of Gross Profit 33.09% 37.7% 13.54% 15.78% 28.47% 25.24% 25.08% 17.45% 16.62% 18.26% 17.67% 53.01% 35.67% 14.67% 40.0% 200.0%
Operating Expenses $1.021B $1.230B $1.756B $1.378B $1.176B $1.161B $1.242B $1.214B $568.1M $236.9M $176.2M $84.31M $51.17M $26.10M $21.70M $38.00M $23.40M $1.100M $1.400M $2.100M $3.100M $8.700M $11.30M $9.500M $5.500M $4.200M $3.400M $3.100M $2.300M
YoY Change -17.06% -29.93% 27.46% 17.15% 1.25% -6.52% 2.34% 113.7% 139.76% 34.5% 108.94% 64.78% 96.05% 20.28% -42.89% 62.39% 2027.27% -21.43% -33.33% -32.26% -64.37% -23.01% 18.95% 72.73% 30.95% 23.53% 9.68% 34.78% 4.55%
Operating Profit -$157.0M -$226.3M $18.75M $57.71M -$274.1M -$171.2M -$276.4M -$96.55M -$120.6M -$145.8M -$79.63M -$37.27M -$23.19M -$11.10M -$20.20M -$37.10M -$23.40M
YoY Change -30.6% -1306.68% -67.51% -121.06% 60.08% -38.07% 186.32% -19.93% -17.31% 83.11% 113.67% 60.72% 108.91% -45.05% -45.55% 58.55%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Interest Expense $13.51M -$9.426M -$18.01M -$21.70M -$19.60M -$7.600M -$5.900M -$4.200M -$47.20M -$22.10M -$59.40M $0.00 -$700.0K -$1.200M -$1.700M $500.0K $1.300M $100.0K $200.0K $700.0K $1.400M $1.500M $200.0K $300.0K $100.0K $200.0K -$400.0K
YoY Change -243.28% -47.65% -17.02% 10.71% 157.89% 28.81% 40.48% -91.1% 113.57% -62.79% -100.0% -41.67% -29.41% -61.54% 1200.0% -50.0% -71.43% -50.0% -6.67% 650.0% -33.33% 200.0% -50.0% -150.0% 300.0%
% of Operating Profit -96.03% -37.6%
Other Income/Expense, Net -$27.30M -$165.3M -$32.78M -$9.031M -$30.91M -$6.072M $4.518M -$271.0K -$39.52M -$25.21M -$24.59M $165.0K -$1.044M $300.0K -$200.0K -$1.400M -$700.0K
YoY Change -83.48% 404.23% 262.93% -70.79% 409.11% -234.4% -1767.16% -99.31% 56.74% 2.55% -15000.61% -115.8% -448.0% -250.0% -85.71% 100.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Pretax Income -$198.4M -$389.4M -$2.965M $81.73M -$236.5M -$132.1M -$247.9M -$92.18M -$113.6M -$84.08M -$74.86M -$34.06M -$24.09M -$12.00M -$24.10M -$39.90M -$267.9M -$600.0K -$200.0K -$1.900M -$5.800M -$10.40M -$8.900M -$7.100M -$3.900M -$2.700M -$3.300M -$2.900M -$2.700M
YoY Change -49.06% 13034.54% -103.63% -134.55% 79.06% -46.72% 168.99% -18.87% 35.13% 12.31% 119.8% 41.38% 100.74% -50.21% -39.6% -85.11% 44550.0% 200.0% -89.47% -67.24% -44.23% 16.85% 25.35% 82.05% 44.44% -18.18% 13.79% 7.41% 17.39%
Income Tax $4.437M -$63.50M $15.49M $17.62M $7.060M -$38.73M $18.86M -$56.12M -$113.7M $24.00K $1.672M -$9.626M -$19.36M $0.00 $0.00 -$100.0K -$100.0K $0.00 $0.00 $0.00 $0.00 $0.00 -$100.0K $100.0K $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income 21.55%
Net Earnings -$188.9M -$328.4M -$30.14M $30.59M -$314.9M -$153.0M -$305.3M -$48.36M -$52.13M -$171.7M -$114.4M -$29.05M -$1.283M -$18.90M -$30.10M -$39.80M -$268.4M -$600.0K -$200.0K -$1.900M -$5.800M -$10.40M -$8.800M -$7.200M -$4.400M -$2.700M -$3.300M -$2.900M -$2.700M
YoY Change -42.49% 989.49% -198.55% -109.71% 105.78% -49.86% 531.22% -7.23% -69.63% 50.05% 293.85% 2164.07% -93.21% -37.21% -24.37% -85.17% 44633.33% 200.0% -89.47% -67.24% -44.23% 18.18% 22.22% 63.64% 62.96% -18.18% 13.79% 7.41% 17.39%
Net Earnings / Revenue -21.87% -32.7% -1.7% 2.13% -34.92% -15.45% -31.6% -4.33% -11.65% -188.39% -118.52% -61.75% -4.59% -66.32% -684.09% -423.4% -33550.0% -1733.33% -676.92% -800.0% -314.29% -225.0%
Basic Earnings Per Share -$0.25 -$0.46 -$0.05 $0.05 -$0.53 -$0.27 -$0.55 -$0.09 -$0.11
Diluted Earnings Per Share -$0.25 -$0.46 -$0.05 $0.05 -$0.53 -$0.27 -$0.55 -$0.10 -$0.11 -$406.9K -$322.2K -$98.04K -$4.631K -$74.09K -$129.1K -$212.0K -$2.084M -$36.59K -$12.27K -$118.0K -$369.4K -$662.4K -$560.5K -$496.6K -$427.2K -$278.4K -$397.6K -$381.6K -$473.7K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Cash & Short-Term Investments $95.90M $153.2M $134.7M $72.20M $85.50M $96.50M $91.50M $168.7M $193.6M $96.90M $185.8M $27.40M $71.50M $18.00M $42.70M $6.700M $23.40M $8.600M $8.900M $9.900M $10.10M $16.10M $25.00M $35.40M $3.200M $6.800M $1.800M $2.900M $5.400M
YoY Change -37.4% 13.72% 86.58% -15.56% -11.4% 5.46% -45.76% -12.86% 99.79% -47.85% 578.1% -61.68% 297.22% -57.85% 537.31% -71.37% 172.09% -3.37% -10.1% -1.98% -37.27% -35.6% -29.38% 1006.25% -52.94% 277.78% -37.93% -46.3%
Cash & Equivalents $95.90M $153.2M $134.7M $72.20M $85.50M $96.50M $91.50M $168.7M $193.6M $96.90M $185.8M $27.40M $71.50M $18.00M $42.70M $6.700M $23.40M $8.600M $8.900M $8.700M $10.10M $6.100M $15.00M $35.40M $3.200M $6.800M $1.800M $2.900M $5.400M
Short-Term Investments $1.100M $0.00 $10.00M $10.10M $0.00
Other Short-Term Assets $213.6M $18.67M $336.2M $16.40M $27.40M $16.90M $15.10M $18.10M $11.90M $6.300M $13.60M $5.500M $1.300M $9.000M $1.000M $1.100M $1.900M $200.0K $100.0K $200.0K $1.200M $1.100M $1.300M $500.0K $100.0K $100.0K $0.00 $0.00 $0.00
YoY Change 1044.33% -94.45% 1950.08% -40.15% 62.13% 11.92% -16.57% 52.1% 88.89% -53.68% 147.27% 323.08% -85.56% 800.0% -9.09% -42.11% 850.0% 100.0% -50.0% -83.33% 9.09% -15.38% 160.0% 400.0% 0.0%
Inventory $65.70M $74.06M $86.50M $132.3M $53.40M $42.30M $49.30M $47.20M $39.70M $16.60M $18.10M $22.30M $13.30M $16.40M $10.50M $4.100M $2.200M
Prepaid Expenses
Receivables $123.4M $127.3M $259.6M $286.3M $134.6M $143.9M $165.5M $220.3M $193.9M $20.00M $19.80M $21.20M $12.50M $11.90M $8.800M $1.000M $1.700M
Other Receivables $6.821M $21.30M $5.951M $16.00M $23.10M $18.10M $27.40M $29.20M $15.00M $3.100M $5.400M $2.300M $900.0K $2.100M $800.0K $600.0K $0.00
Total Short-Term Assets $309.5M $394.5M $823.0M $523.2M $324.0M $317.7M $348.9M $483.6M $454.1M $142.9M $242.7M $78.70M $99.60M $57.40M $63.80M $13.50M $29.20M $8.800M $9.000M $10.10M $11.30M $17.30M $26.30M $35.90M $3.300M $6.900M $1.900M $2.900M $5.500M
YoY Change -21.55% -52.06% 57.3% 61.48% 1.98% -8.94% -27.85% 6.5% 217.77% -41.12% 208.39% -20.98% 73.52% -10.03% 372.59% -53.77% 231.82% -2.22% -10.89% -10.62% -34.68% -34.22% -26.74% 987.88% -52.17% 263.16% -34.48% -47.27%
Property, Plant & Equipment $143.5M $121.6M $124.0M $178.3M $166.5M $144.7M $146.6M $122.8M $131.8M $16.40M $17.00M $16.50M $5.400M $2.600M $600.0K $700.0K $400.0K $0.00 $0.00 $0.00 $0.00 $200.0K $1.000M $500.0K $300.0K $100.0K $100.0K $100.0K $100.0K
YoY Change 18.02% -1.9% -30.48% 7.09% 15.07% -1.3% 19.38% -6.83% 703.66% -3.53% 3.03% 205.56% 107.69% 333.33% -14.29% 75.0% -100.0% -80.0% 100.0% 66.67% 200.0% 0.0% 0.0% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $16.08M $28.08M $10.73M $15.70M $20.60M $30.40M $37.30M $37.10M $29.40M $16.10M $24.70M $15.60M $6.700M $5.100M $4.400M $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -42.73% 161.72% -31.66% -23.79% -32.24% -18.5% 0.54% 26.19% 82.61% -34.82% 58.33% 132.84% 31.37% 15.91%
Other Assets $908.9M $8.679M $9.534M $10.10M $7.000M $8.100M $8.900M $9.800M $10.20M $12.20M $12.80M $2.800M $1.300M $100.0K $400.0K $200.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change 10372.4% -8.97% -5.6% 44.29% -13.58% -8.99% -9.18% -3.92% -16.39% -4.69% 357.14% 115.38% 1200.0% -75.0% 100.0%
Total Long-Term Assets $1.702B $1.773B $1.577B $1.950B $1.985B $2.133B $2.241B $2.283B $2.345B $1.125B $1.149B $211.1M $129.9M $20.40M $23.60M $8.300M $10.40M $0.00 $0.00 $0.00 $0.00 $200.0K $1.300M $1.500M $1.200M $800.0K $900.0K $1.000M $1.000M
YoY Change -3.98% 12.43% -19.14% -1.78% -6.94% -4.81% -1.84% -2.65% 108.49% -2.09% 444.2% 62.51% 536.76% -13.56% 184.34% -20.19% -100.0% -84.62% -13.33% 25.0% 50.0% -11.11% -10.0% 0.0%
Total Assets $2.012B $2.167B $2.400B $2.473B $2.309B $2.451B $2.590B $2.767B $2.799B $1.268B $1.392B $289.8M $229.5M $77.80M $87.40M $21.80M $39.60M $8.800M $9.000M $10.10M $11.30M $17.50M $27.60M $37.40M $4.500M $7.700M $2.800M $3.900M $6.500M
YoY Change
Accounts Payable $69.70M $66.99M $82.04M $100.9M $62.50M $47.40M $74.30M $53.40M $72.50M $8.700M $13.40M $10.20M $4.900M $6.500M $4.800M $2.200M $3.300M $700.0K $300.0K $200.0K $1.000M $1.200M $1.200M $600.0K $700.0K $500.0K $500.0K $300.0K $200.0K
YoY Change 4.04% -18.34% -18.69% 61.44% 31.86% -36.2% 39.14% -26.34% 733.33% -35.07% 31.37% 108.16% -24.62% 35.42% 118.18% -33.33% 371.43% 133.33% 50.0% -80.0% -16.67% 0.0% 100.0% -14.29% 40.0% 0.0% 66.67% 50.0%
Accrued Expenses $90.10M $107.1M $202.6M $231.7M $154.9M $133.5M $160.6M $117.1M $84.70M $56.70M $57.50M $21.50M $3.700M $2.800M $3.100M $5.000M $3.900M
YoY Change -15.86% -47.14% -12.56% 49.58% 16.03% -16.87% 37.15% 38.25% 49.38% -1.39% 167.44% 481.08% 32.14% -9.68% -38.0% 28.21%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $39.40M $16.95M $27.20M $12.40M $40.70M $15.30M $15.00M $16.80M $13.40M $11.00M $17.50M $8.800M $14.70M $4.300M $100.0K $2.500M $0.00 $100.0K $100.0K $0.00
YoY Change -100.0% 132.42% -37.68% 119.35% -69.53% 166.01% 2.0% -10.71% 25.37% 21.82% -37.14% 98.86% -40.14% 241.86% 4200.0% -96.0% -100.0% 0.0%
Total Short-Term Liabilities $200.1M $213.5M $330.0M $375.5M $249.1M $288.3M $312.0M $263.3M $251.9M $83.10M $91.90M $52.40M $18.80M $27.60M $13.00M $7.700M $9.700M $700.0K $300.0K $200.0K $1.000M $1.300M $1.300M $900.0K $1.000M $700.0K $600.0K $400.0K $200.0K
YoY Change -6.27% -35.31% -12.12% 50.74% -13.6% -7.6% 18.5% 4.53% 203.13% -9.58% 75.38% 178.72% -31.88% 112.31% 68.83% -20.62% 1285.71% 133.33% 50.0% -80.0% -23.08% 0.0% 44.44% -10.0% 42.86% 16.67% 50.0% 100.0%
Long-Term Debt $214.3M $226.6M $193.1M $228.6M $263.9M $172.8M $142.7M $73.70M $109.2M $67.90M $114.1M $5.200M $0.00 $0.00 $15.30M $13.70M $13.10M $0.00 $0.00 $0.00 $0.00 $100.0K $200.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -5.41% 17.34% -15.54% -13.38% 52.72% 21.09% 93.62% -32.51% 60.82% -40.49% 2094.23% -100.0% 11.68% 4.58% -100.0% -50.0%
Other Long-Term Liabilities $81.30M $39.15M $43.01M $60.20M $62.80M $83.50M $142.9M $172.5M $232.3M $113.7M $146.2M $19.20M $18.60M $100.0K $0.00 $800.0K $900.0K $1.000M $1.100M $1.200M $1.300M
YoY Change 107.68% -8.98% -28.55% -4.14% -24.79% -41.57% -17.16% -25.74% 104.31% -22.23% 661.46% 3.23% 18500.0% -100.0% -11.11% -10.0% -9.09% -8.33% -7.69%
Total Long-Term Liabilities $295.6M $265.7M $236.1M $288.8M $326.7M $256.3M $285.6M $246.2M $341.5M $181.6M $260.3M $24.40M $18.60M $100.0K $15.30M $13.70M $13.10M $0.00 $0.00 $0.00 $0.00 $100.0K $200.0K $800.0K $900.0K $1.000M $1.100M $1.200M $1.300M
YoY Change 11.25% 12.54% -18.25% -11.6% 27.47% -10.26% 16.0% -27.91% 88.05% -30.23% 966.8% 31.18% 18500.0% -99.35% 11.68% 4.58% -100.0% -50.0% -75.0% -11.11% -10.0% -9.09% -8.33% -7.69%
Total Liabilities $622.5M $605.6M $714.6M $801.5M $694.5M $659.8M $746.3M $674.8M $819.4M $425.5M $515.1M $86.10M $44.20M $28.70M $29.70M $21.40M $22.80M $700.0K $300.0K $200.0K $1.000M $1.400M $1.500M $1.600M $1.900M $1.700M $1.700M $1.600M $1.500M
YoY Change 2.79% -15.25% -10.84% 15.41% 5.26% -11.59% 10.6% -17.65% 92.57% -17.39% 498.26% 94.8% 54.01% -3.37% 38.79% -6.14% 3157.14% 133.33% 50.0% -80.0% -28.57% -6.67% -6.25% -15.79% 11.76% 0.0% 6.25% 6.67%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Basic Shares Outstanding 751.8M 719.1M shares 648.1M shares 640.7M shares 595.5M shares 563.1M shares 559.2M shares 550.8M shares 488.1M shares
Diluted Shares Outstanding 719.1M shares 648.1M shares 640.7M shares 595.5M shares 563.1M shares 559.2M shares 555.6M shares 488.1M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $1.0647 Billion

About OPKO HEALTH, INC.

OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. The company is headquartered in Miami, Florida and currently employs 3,930 full-time employees. The firm focuses on leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. Its segments include pharmaceutical and diagnostics. The pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain, Rayaldee product sales and its pharmaceutical research and development. The diagnostics segment primarily consists of point-of-care operations. Its pharmaceutical business features Rayaldee, a United States Food and Drug Administration (FDA) approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage three or four chronic kidney disease (CKD) and vitamin D insufficiency, and Somatrogon (hGH-CTP), a once-weekly human growth hormone injection. Its NGENLA (somatrogon-ghla), is a once-weekly, human growth hormone analog indicated for treatment of pediatric patients aged three years and older.

Industry: Pharmaceutical Preparations Peers: 23andMe Holding Co. Addus HomeCare Corp AGILITI, INC. \DE Astrana Health, Inc. CVS HEALTH Corp Pediatrix Medical Group, Inc. ModivCare Inc